Mesoblast Limited vs Star Bulk Carriers Corp — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Star Bulk Carriers Corp trades at $27.66 (market cap $3.09B). The key difference: Star Bulk Carriers Corp is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.79% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | SBLK | |
|---|---|---|
Market Cap | $2.21B | $3.09B |
Sector | Technology | Industrials |
52-Week High | $20.96 | $29.15 |
52-Week Low | $12.88 | $16.79 |
Enterprise Value | $2.21B | $3.77B |
Dividend Yield | — | 6.79% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →